Skip to main content

Table 1 Parameters for evaluating the anti-amastigote activity of larval-products

From: The therapeutic effect of larval saliva and hemolymph of Lucilia sericata on the treatment of Leishmania major lesion in BALB/c mice946

Parameter

Abbreviation

Equation

Infection percentage

I %

(Infected cells/100 randomly-chosen cells) × 100

Decreased in infection percentage

DI %

[(%I no treatment—%I treatment)/%I no treatment] × 100

Viability of amastigote percentage

V %

(amastigote treatment/amastigote no treatment) × 100

Decreased viability of amastigote percentage

DV %

[(amastigote no treatment—(amastigote treatment/no treatment] × 100

Parasite load

PL

amastigotes/infected cells

Survival index

SVI

%I × PL

Selectivity index

SI

CC50/IC50